A Phase 1/2a Study of ABT-263 in Subjects With Small Cell Lung Cancer (SCLC) or Other Non-Hematological Malignancies

Clinical trial NCT00445198 · COMPLETED

Trial details

NCT number: NCT00445198
Sponsor: AbbVie (prior sponsor, Abbott)
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Small Cell Lung Carcinoma

Start date: 2007-04-01
Primary completion: 2010-12-01
Enrollment: 86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.